1. Home
  2. MRUS vs LAUR Comparison

MRUS vs LAUR Comparison

Compare MRUS & LAUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • LAUR
  • Stock Information
  • Founded
  • MRUS 2003
  • LAUR 1989
  • Country
  • MRUS Netherlands
  • LAUR United States
  • Employees
  • MRUS N/A
  • LAUR N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • LAUR Other Consumer Services
  • Sector
  • MRUS Health Care
  • LAUR Real Estate
  • Exchange
  • MRUS Nasdaq
  • LAUR Nasdaq
  • Market Cap
  • MRUS 4.1B
  • LAUR 3.4B
  • IPO Year
  • MRUS 2016
  • LAUR 2017
  • Fundamental
  • Price
  • MRUS $66.82
  • LAUR $23.27
  • Analyst Decision
  • MRUS Strong Buy
  • LAUR Buy
  • Analyst Count
  • MRUS 13
  • LAUR 2
  • Target Price
  • MRUS $88.54
  • LAUR $20.50
  • AVG Volume (30 Days)
  • MRUS 645.9K
  • LAUR 1.3M
  • Earning Date
  • MRUS 08-04-2025
  • LAUR 07-31-2025
  • Dividend Yield
  • MRUS N/A
  • LAUR N/A
  • EPS Growth
  • MRUS N/A
  • LAUR 143.51
  • EPS
  • MRUS N/A
  • LAUR 1.90
  • Revenue
  • MRUS $54,732,000.00
  • LAUR $1,527,432,000.00
  • Revenue This Year
  • MRUS $68.08
  • LAUR $2.45
  • Revenue Next Year
  • MRUS $0.09
  • LAUR $6.85
  • P/E Ratio
  • MRUS N/A
  • LAUR $12.17
  • Revenue Growth
  • MRUS 42.77
  • LAUR 1.26
  • 52 Week Low
  • MRUS $33.19
  • LAUR $13.60
  • 52 Week High
  • MRUS $67.07
  • LAUR $24.57
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 77.27
  • LAUR 50.79
  • Support Level
  • MRUS $61.51
  • LAUR $22.53
  • Resistance Level
  • MRUS $64.00
  • LAUR $24.57
  • Average True Range (ATR)
  • MRUS 2.32
  • LAUR 0.64
  • MACD
  • MRUS 1.02
  • LAUR -0.14
  • Stochastic Oscillator
  • MRUS 97.35
  • LAUR 36.27

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About LAUR Laureate Education Inc.

Laureate Education Inc is an international community of universities. The company provides higher education programs and services to students through an international network of licensed universities and higher education institutions. Its geographical segments include Peru and Mexico.

Share on Social Networks: